Toggle sidebar
Toggle sidebar
全部
R1
智能回答
Search
Search
定价
登录
AKRO Today Is the Last Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
Akero(AKRO)
Prnewswire
·
2024-06-25 15:00